European Equities Traded in the US as American Depositary Receipts Tracking Higher in Thursday Trading

MT Newswires Live
Yesterday

European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.43% to 1,852.92 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and 3D printer company Materialise (MTLS), which climbed 11.4% and 10.4% respectively. They were followed by lender ING Group (ING) and biopharmaceutical company Cellectis (CLLS), which increased 2.3% and 2.1% respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and internet browser company Opera (OPRA), which fell 1.7% and 1.6% respectively. They were followed by oil and gas company Eni (E) and lender Banco Santander (SAN), which were off 1.3% and 0.5% respectively.

The gainers from the UK were led by biopharmaceutical companies NuCana (NCNA) and Akari Therapeutics (AKTX), which advanced 9.6% and 3.2% respectively. They were followed by communications company WPP (WPP) and lender Barclays (BCS), which were up 2.8% and 2.4% respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and mining company BHP Group (BHP), which dropped 9.9% and 2.1% respectively. They were followed by biopharmaceutical company Amarin (AMRN) and pharmaceutical company AstraZeneca (AZN), which were down 1.3% each.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10